Horizon 2020 program selects Precision NanoSystems’ NanoAssemblr platform to develop RNA medicines April 3, 2017 Posted in: Device / Technology News | Life Sciences News | Pharmaceutical News Tags: Brain, EU, Laboratory, Molecule, Nanoparticles, Nucleotide, Polynucleotide, Research Project, RNA, therapeutics